In another study, Skladany et al. measured serum myostatin in 395 hospitalized patients with cirrhosis and controls, with a median follow up of 256 days and found that higher myostatin levels were correlated with higher muscle mass and better function, measured by MAMC, transversal psoas muscle index and HGS.20 The gene discussed is MSTN; the disease is Cirrhosis.